Page 4 - குறுகிய கால முதலீடுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from குறுகிய கால முதலீடுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In குறுகிய கால முதலீடுகள் Today - Breaking & Trending Today

Precigen Reports Fourth Quarter and Full Year 2020 Financial Results


Precigen Reports Fourth Quarter and Full Year 2020 Financial Results
- Company successfully accomplished anticipated 2020 clinical milestones despite challenges due to the ongoing pandemic -
- Strengthened balance sheet with successful public offering while streamlining operations and reducing operating costs -
- Initial data readouts from PRGN-3005 and PRGN-3006 UltraCAR-T® clinical trials demonstrated encouraging expansion, persistence and clinical activity -
- A PRGN-3006 UltraCAR-T patient achieved complete remission with incomplete hematologic recovery (CRi) per ELN criteria -
- Initiated first AdenoVerse™ immunotherapy clinical trial for PRGN-2009 in HPV-associated solid tumors -
- Interim data for AG019 ActoBiotics™ in T1D indicate encouraging trends in C-peptide levels and ability to induce antigen-specific immune modulation following only one treatment cycle of oral AG019 as monotherapy or combination - ....

United States , Precigen Actobio , Helen Sabzevari , Development Agreement , National Cancer Institute , H Lee Moffitt Cancer Center Research Institute , Drug Administration , Intrexon Corporation , Cancer Research , American Society Of Hematology , University Of Washington , Fred Hutchinson Cancer Research Center , Precigen Inc , Fred Hutchinson Cancer Research , Clinical Data , Moffitt Cancer Center , Drug Designation , Orphan Drug Designation , American Society , European Leukemia Net , Patients Dosed , Cooperative Research , Patient Dosed , Preclinical Data , Six Month Follow Up , Precigen Triple Gene ,

Pan American Silver reports record operating cash flow of $462.3 million in 2020


VANCOUVER, BC, Feb. 17, 2021 /PRNewswire/ -
Pan American Silver Corp. (NASDAQ: PAAS ) (TSX: PAAS) ( Pan American or the Company ) today reported audited financial results for the year ended December 31, 2020 ( FY 2020 ) and the fourth quarter ( Q4 2020 ). Preliminary production results were previously reported on January 19, 2021. Pan American s audited consolidated financial statements ( Financial Statements ), as well as Pan American s Management s Discussion and Analysis ( MD & A ) for the three and twelve months ended December 31, 2020, and the Company s Annual Information Form for the year ended December 31, 2020, are available on Pan American s website at panamericansilver.com and on SEDAR at  .
Pan American delivered strong financial performance in 2020, generating a record $462.3 million in operating cash flow, which enabled us to fully repay all bank debt, double our quarterly dividend to shareholders, and grow our cash balance at year end, said Michael ....

United States , La Arena , British Columbia , La Colorada , Martin Wafforn , Christopher Emerson , Manantial Espejo , Michael Steinmann , Technical Services , Canadian National Instrument , Company Annual Information Form , Exchange Commission , Pan American Silver Corp , Toronto Stock Exchange , Business Development , American Silver , Pan American , Annual Information Form , Chief Executive , San Vicente , Segment Cash Costs , All In Sustaining Costs , Gold Segment , Income Tax Act , Cash Costs , Segment Consolidated ,